AI assistant
Sending…
ALLIANCE PHARMA PLC — Share Issue/Capital Change 2018
Jan 2, 2018
7478_rns_2018-01-02_f0422ff2-cb7c-473f-b692-da088ebb6312.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6116A
Alliance Pharma PLC
02 January 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Block Listing Six Monthly Return
| Name of applicant: | ALLIANCE PHARMA PLC | |||
| Names of schemes: | a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Company Share Option Plan 2015 |
|||
| Period of return: | From: | 28 June 2017 | To: | 28 December 2017 |
| Number of securities originally admitted at date of admission: | 25,000,000 ordinary shares of 1p each 28 June 2017 |
|||
| Balance of unallotted securities under schemes from previous return: | a) 2,248,922 b) 19,461,225 c) 3,289,853 |
|||
| Plus: The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for): | a) Nil b) Nil c) Nil |
|||
| Less: Number of securities issued/allotted under schemes during period: | a) 326,427 b) 355,982 c) Nil |
|||
| Equals: Balance under schemes not yet issued/allotted at end of period: | a) 1,922,495 b) 19,105,243 c) 3,289,853 |
|||
| Name of contact: | Marie-Claire Haines, Assistant Company Secretary |
| Telephone number of contact: | Tel. +44 (0)1249 705166 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRUKAURBKAUUAA
More from ALLIANCE PHARMA PLC
Delisting Announcement
2025
May 15
AGM Information
2025
May 14
M&A Activity
2025
May 12
Major Shareholding Notification
2025
May 1
Major Shareholding Notification
2025
Apr 29
Major Shareholding Notification
2025
Apr 29
Director's Dealing
2025
Apr 28
Regulatory Filings
2025
Apr 23
Regulatory Filings
2025
Apr 22
Report Publication Announcement
2025
Apr 9